The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen

Cancer Res. 2006 Feb 15;66(4):2224-32. doi: 10.1158/0008-5472.CAN-05-1619.

Abstract

In sporadic breast cancers, BRCA-1 expression is down-regulated in the absence of mutations in the BRCA-1 gene. This suggests that disruption of BRCA-1 expression may contribute to the onset of mammary tumors. Environmental contaminants found in industrial pollution, tobacco smoke, and cooked foods include benzo(a)pyrene [B(a)P] and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which have been shown to act as endocrine disruptors and tumor promoters. In previous studies, we documented that estrogen (E2) induced BRCA-1 transcription through the recruitment of an activator protein-1/estrogen receptor-alpha (ER alpha) complex to the proximal BRCA-1 promoter. Here, we report that activation of BRCA-1 transcription by E2 requires occupancy of the BRCA-1 promoter by the unliganded aromatic hydrocarbon receptor (AhR). The stimulatory effects of E2 on BRCA-1 transcription are counteracted by (a) cotreatment with the AhR antagonist 3'-methoxy-4'-nitroflavone; (b) transient expression in ER alpha-negative HeLa cells of ER alpha lacking the protein-binding domain for the AhR; and (c) mutation of two consensus xenobiotic-responsive elements (XRE, 5'-GCGTG-3') located upstream of the ER alpha-binding region. These results suggest that the physical interaction between the unliganded AhR and the liganded ER alpha plays a positive role in E2-dependent activation of BRCA-1 transcription. Conversely, we show that the AhR ligands B(a)P and TCDD abrogate E2-induced BRCA-1 promoter activity. The repressive effects of TCDD are paralleled by increased recruitment of the liganded AhR and HDAC1, reduced occupancy by p300, SRC-1, and diminished acetylation of H4 at the BRCA-1 promoter region flanking the XREs. We propose that the ligand status of the AhR modulates activation of the BRCA-1 promoter by estrogen.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • BRCA1 Protein / biosynthesis
  • BRCA1 Protein / genetics
  • Benzo(a)pyrene / metabolism
  • Benzo(a)pyrene / pharmacology
  • Breast Neoplasms / genetics
  • Estradiol / pharmacology*
  • Estrogen Receptor alpha / metabolism*
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Expression Regulation, Neoplastic / physiology
  • Genes, BRCA1 / drug effects
  • Genes, BRCA1 / physiology*
  • HeLa Cells
  • Humans
  • Ligands
  • Polychlorinated Dibenzodioxins / metabolism
  • Polychlorinated Dibenzodioxins / pharmacology
  • Promoter Regions, Genetic / drug effects
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Receptor Cross-Talk / drug effects
  • Receptor Cross-Talk / physiology
  • Receptors, Aryl Hydrocarbon / antagonists & inhibitors
  • Receptors, Aryl Hydrocarbon / metabolism*
  • Transcription Factor AP-1 / metabolism
  • Transcriptional Activation / drug effects
  • Transcriptional Activation / physiology
  • Transfection

Substances

  • BRCA1 Protein
  • Estrogen Receptor alpha
  • Ligands
  • Polychlorinated Dibenzodioxins
  • RNA, Messenger
  • Receptors, Aryl Hydrocarbon
  • Transcription Factor AP-1
  • Benzo(a)pyrene
  • Estradiol